Effect of thromboxane A2 inhibitors on allergic pulmonary inflammation in mice

European Respiratory Journal

Volumn 11, Issue 3, 1998, Pages 624-629

  Shi, H ^a   Yokoyama, A ^a   Kohno, N ^a   Hirasawa, Y ^a   Kondo, K ^a   Sakai, K ^a   Hiwada, K ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; Cytokine; Eosinophil; OKY 046; S 1452; Thromboxane A2

Indexed keywords

CYTOKINE; DOMITROBAN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 5; OZAGREL; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; 7 (3 BENZENESULFONAMIDOBICYCLO[2.2.1]HEPT 2 YL) 5 HEPTENOIC ACID; BICYCLO COMPOUND; ENZYME INHIBITOR; METHACRYLIC ACID DERIVATIVE; MONOUNSATURATED FATTY ACID; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; THROMBOXANE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; EOSINOPHIL; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; ANIMAL; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CYTOLOGY; DRUG ANTAGONISM; IMMUNOLOGY; LOEFFLER PNEUMONIA; LUNG LAVAGE; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; ASTHMA; BICYCLO COMPOUNDS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; ENZYME INHIBITORS; FATTY ACIDS, MONOUNSATURATED; METHACRYLATES; MICE; MICE, INBRED BALB C; PROSTAGLANDIN ANTAGONISTS; PULMONARY EOSINOPHILIA; THROMBOXANE-A SYNTHASE;

EID: 0031596999     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 2. Federation Proc 1987; 46: 133-138.
2. 2 production in allergen-induced immediate and late asthmatic responses. J Asthma 1988; 25: 117-124.
3. Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to broncho-protective mediators. Am Rev Respir Dis 1989; 139: 450-457.
4. Manning PJ, Stevens WH, Cockcroft DW, O'Byrne PM. The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J 1991; 4: 667-672.
5. 2 in the pathogenesis of airway hyperresponsiveness. Eur Respir J 1989; 2: 782-786.
6. Nüsing R, Lesch R, Ullrich V. Immunohistochemical localization of thromboxane synthase in human tissues. Eicosanoids 1990; 3: 53-58.
7. Nüsing R, Ullrich V. Immunoquantitation of thromboxane synthase in human tissues. Eicosanoids 1990; 3: 175-180.
8. 2 receptor: cDNA cloning, expression and northern blot analysis. Biochem Biophys Res Commun 1992; 184: 1197-1203.
9. 2 receptor is highly expressed in mouse immature thymocytes and mediates DNA fragmentation and apoptosis. J Exp Med 1993; 178: 1825-1830.
10. Busse WW, Calhoun WF, Sedgwick JD. Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993; 147: S20-S24.
11. Johnston SL, Freezer NJ, Ritter W, O'Toole, Howarth PH. Prostaglandin D2-induced bronchoconstriction is mediated only in part by the thromboxane prostanoid receptor. Eur Respir J 1995; 8: 411-415.
12. Aizawa H, Chung KF, Leikauf GD, et al. Significance of thromboxane generation in ozone-induced airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59: 1918-1923.
13. 4 induces airway hyperresponsiveness in dogs. J Appl Physiol 1985; 59: 1941-1946.
14. Chung KF, Aizawa H, Leikauf GD, Ueki IF, Evans TW, Nadel JA. Airway hyperresponsiveness induced by platelet-activating factor: role of thromboxane generation. J Pharm Exp Ther 1986; 236: 580-584.
15. Chung KF, Aizawa H, Becker AB, Frick O, Gold WM, Nadel JA. Inhibition of antigen-induced airway hyperresponsiveness by a thromboxane synthase inhibitor (OKY-046) in allergic dogs. Am Rev Respir Dis 1986; 134: 258-261.
16. 2 inhibitors in guinea pigs. Biol Pharm Bull 1993; 16: 1099-1103.
17. 2 synthetase inhibitor, OKY-046, on sputum in chronic bronchitis and diffuse panbronchiolitis. Eur Respir J 1995; 8: 1705-1711.
18. Fujimura M, Kamio Y, Kasahara K, Bando T, Hashimoto T, Matsuda T. Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 1995; 8: 1499-1505.
19. 2 in bronchial hyperresponsiveness but not lung inflammation induced by bacterial lipopolysaccharide in guinea-pigs. Eur J Pharmacol 1993; 231: 13-21.
20. 2) receptor antagonist (S-1452) on the antigen-induced bronchoconstriction and airway hyperresponsiveness in guinea pigs. Prostaglandins Leukot Essent Fatty Acids 1993; 48: 343-349.
21. 2 receptor antagonist, S-1452, on antigen-induced sustained bronchial hyperresponsiveness. Eur J Pharmacol 1994; 260: 201-209.
22. Yokoyama A, Evavold B, Dunn DE, Quintans J. Production of IL-2 and IFN by Th2 clones. Immunol Lett 1989; 21: 119-126.
23. Ohnishi T, Kita H, Weiler D, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993; 147: 901-907.
24. Knol EF, Roos D. Mechanisms regulating eosinophil extravasation in asthma. Eur Respir J 1996; 22: S136-S140.
25. Nakajima H, Iwamoto I, Tomoe S, et al. CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am Rev Respir Dis 1992; 146: 374-377.
26. 2 on lymphocyte proliferation. Cell Immunol 1985; 90: 458-463.
27. Kuhn DC, Stauffer JL, Gaydos W, Lacey SL, Demers LM. An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages. Prostaglandins 1993; 46: 195-205.
28. 2 in nonadherent human monocytes. J Immunol 1997; 158: 351-358.
29. 2 antagonist, S-1452, in guinea pigs. Int Arch Allergy Immunol 1992; 98: 239-246.
30. Alabaster VA, Moore BA. Drug intervention in asthma: present and future. Thorax 1993; 48: 176-182.
31. Thien FCK, Walters EH. Eicosanoids and asthma: an update. Prostaglandins Leukot Essent Fatty Acids 1995; 52: 271-288.